Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo.
Biochem J
; 479(9): 1007-1030, 2022 05 13.
Article
in En
| MEDLINE
| ID: mdl-35470373
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polysaccharides
/
Lectins
Limits:
Animals
Language:
En
Journal:
Biochem J
Year:
2022
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United kingdom